-
Foundation
Astra AB pharmaceutical was founded in 1913 and headquartered in Södertälje, Sweden -
Imperial Chemical Industries (ICI)
Imperial Chemical Industries (ICI) was formed in the UK -
1940´s Developed products
Company launched anesthetics and other innovated products: Xylocaine (lidocaine), Thyreototal (thyoidea),Follidrin (oestradiol/oestrone), Tonocard (nicetamide) -
1950´s New medicines
Company developed new medicines: Hibitane, Fluothane, Bamyl, Meproban, Tetradecin, Probecillin,Ferromyn, Diminal, Diurgin, Secergan and Ascoxal -
Pharma business
Pharmaceuticals business was formed in 1957 after ICI grows pharmaceuticals business in the 1940s and 50s) -
1970´s Cardiovascular
The company introduced the first cardiovascular brands to the pharma market -
Oncology and molecular vaccines
Molecular Vaccines Inc was founded in Gaithersburg, US (It was renamed MedImmune in 1990) -
Nobel Prize for Medicine
Sir James Black, pioneer of beta blockers for cardiovascular diseases (researcher at ICI in the late 1950s and early 1960s), was awarded the Nobel Prize in Medicine. -
Born Astra Zeneca
AstraZeneca was born through the merger with Astra AB of Sweden and Zeneca Group PLC of the UK -
Global leadership position
AZ launches blockbuster brands and bought innovative companies as a MedImmune, Arrow Therapeutics, Cambridge Antibody Technology and KuDOS Pharmaceuticals -
Alliance AstraZeneca and Bristol-Myers in Diabetes
AstraZeneca and Bristol Myers Squibb signed the alliance in the diabetes market through the acquisition of Amylin Pharmaceuticals by Bristol-Myers Squibb -
Acquisition plan
Company completed acquisition of AlphaCore Pharma, Omthera Pharmaceuticals, Pearl Therapeutics and Amplimmune
